Development of the University of Queensland’s vaccine candidate remains CSL’s priority.
However, we are currently in discussions with AstraZeneca and the Australian Government to assess whether it is possible to provide local manufacturing support for the Oxford University/AstraZeneca vaccine, should it prove successful, while protecting our commitment to the UQ vaccine.
We are assessing the viability of options ranging from the fill and finish of bulk product imported to Australia through to manufacture of the vaccine candidate under licence.
There are a number of technical issues to work through and discussions are ongoing.
About CSL
/Public Release. View in full .
